Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1983 | 12-1982 | 12-1981 | 12-1980 | 12-1979 | |
| Sales | 3,033,700 | 2,962,711 | 2,773,205 | 2,558,637 | 2,250,824 |
| Cost of Goods | 1,103,200 | 1,129,094 | 1,083,734 | 1,023,515 | 873,184 |
| Gross Profit | 1,930,500 | 1,833,617 | 1,689,471 | 1,535,122 | 1,377,640 |
| Operating Expenses | 1,205,800 | 1,162,773 | 1,073,596 | 970,330 | 836,293 |
| Operating Income | 724,900 | 670,938 | 616,609 | 565,307 | 541,531 |
| Interest Expense | 33,500 | 26,690 | 22,174 | 18,442 | 11,474 |
| Other Income | 63,400 | 39,909 | 51,555 | 43,476 | 29,122 |
| Pre-tax Income | 754,800 | 684,157 | 645,990 | 590,341 | 559,179 |
| Income Tax | 297,400 | 272,329 | 271,512 | 248,367 | 225,503 |
| Net Income Continuous | 457,400 | 411,828 | 374,478 | 341,974 | 333,676 |
| Net Income | $457,400 | $411,828 | $374,478 | $341,974 | $333,676 |
| EPS Basic Total Ops | 0.39 | 0.34 | 0.31 | 0.28 | N/A |
| EPS Basic Continuous Ops | 0.39 | 0.34 | 0.31 | 0.28 | N/A |
| EPS Diluted Total Ops | 0.39 | 0.34 | 0.31 | 0.28 | N/A |
| EPS Diluted Continuous Ops | 0.39 | 0.34 | 0.31 | 0.28 | N/A |
| EBITDA(a) | $724,900 | $670,938 | $616,609 | $565,307 | $541,531 |